|
|
|
|
|
By Tom von Gunden, chief editor, Drug Delivery Leader | At the AFDO/RAPS Combination Products Summit, a notable focus emerged around approaches to risk assessment and human factors studies. In this article, Chief Editor Tom von Gunden offers his appreciation for the biopharma industry’s consideration of patient usability and safety in the development and regulation of combination products and other drug delivery devices. | |
|
|
|
|
| Implantable Drug Delivery: Are We There Yet? | Article | By Breck Petrillo, Battelle | Implantable drug delivery offers precise, localized treatment, yet biological barriers and market complexities remain. Explore the factors determining if these systems are ready for broad adoption. |
|
|
|
|
| Subcutaneous Delivery Innovations For Large-Volume Complex Biologics | Article | By Beth McBride DiLauri, BD Medical - Pharmaceutical Systems | Investigate the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management. |
|
|
|
|
|
.png){kind=logo}
